Clene Reports First Quarter 2026 Financial Results and Recent Operating Highlights
Clene Reports First Quarter 2026 Financial Results and Recent Operating Highlights
Unusual Whales
In Salt Lake City on May 14, 2026, Clene Inc. (Nasdaq: CLNN) and its subsidiary Clene Nanomedicine Inc. revealed their Q1 2026 financial results. Clene is a clinical biopharmaceutical company striving to transform the treatment of neurodegenerative ailments like ALS and MS. They highlighted advancements in their CNM-Au8 initiatives.
